Lichen China Limited Class A Ordinary Shares (LICN) has had the lowest return this month by a US stock in the Nasdaq Composite (IXIC), returning -86.3%.

ASSET	MONTH	% RETURN
Lichen China Limited Class A Ordinary Shares (LICN)	December 2024	-86.29%
Relmada Therapeutics (RLMD)	December 2024	-86.04%
CervoMed (CRVO)	December 2024	-84.67%
Cellectar Biosciences (CLRB)	December 2024	-80.44%
Mynaric AG ADR (MYNA)	December 2024	-69.86%
Canoo (GOEV)	December 2024	-67.65%
VCI Global Limited Ordinary Share (VCIG)	December 2024	-61.42%
Medirom Healthcare Technologies (MRM)	December 2024	-53.53%
Revelation Biosciences (REVB)	December 2024	-50.88%
Tff Pharmaceuticals (TFFP)	December 2024	-50.7%
Palladyne AI (PDYN)	December 2024	-47.2%
BTC Digital (BTCT)	December 2024	-46.2%
Sharps Technology (STSS)	December 2024	-45.07%
Wang & Lee Group, Inc Ordinary Shares (WLGS)	December 2024	-43.89%
Palisade Bio (PALI)	December 2024	-42.86%
Red Cat (RCAT)	December 2024	-41.21%
Mawson Infrastructure (MIGI)	December 2024	-40.83%
Agrify (AGFY)	December 2024	-40.75%
LuxUrban Hotels (LUXH)	December 2024	-40.51%
X3 (XTKG)	December 2024	-40.12%
Cabaletta Bio (CABA)	December 2024	-39.55%
Applied Therapeutics (APLT)	December 2024	-39.36%
NLS Pharmaceutics (NLSP)	December 2024	-39.09%
American Lithium Corp Common Stock (AMLI)	December 2024	-38.7%
Mobix Labs (MOBX)	December 2024	-38.51%